Profile of Shingles Patients in Outpatient Settings Dermatology and Venereology

Laura Noviani; Harijono Kariosentono; Aulia Yasmin; Nila Kusumasari

doi:10.37899/journallamedihealtico.v5i4.1498

Laura Noviani RSUD Dr. Moewardi, Faculty of Medicine, Sebelas Maret University, Surakarta
Harijono Kariosentono RSUD Dr. Moewardi, Faculty of Medicine, Sebelas Maret University, Surakarta
Aulia Yasmin RSUD Dr. Moewardi, Faculty of Medicine, Sebelas Maret University, Surakarta
Nila Kusumasari RSUD Dr. Moewardi, Faculty of Medicine, Sebelas Maret University, Surakarta

DOI: https://doi.org/10.37899/journallamedihealtico.v5i4.1498

Keywords: Herpes Zoster, Immunocompromised, Profile, Varicella, Reccurent, Varicella Zoster Virus

Abstract

Herpes zoster (HZ) is a latent varicella zoster virus (VZV) reactivation has been related to aging and immunocompromised condition that affects the skin and mucosa. It becomes increasingly common. However, studies on the clinical profile of HZ in Indonesia are still lacking. Objective of the study is to describe clinico-epidemiological profiles of HZ in Dr. Moewardi General Hospital Surakarta, Indonesia in the period of January 2018 – December 2022. We conducted a retrospective study using the medical records of patients visiting Dermatovenereology Outpatient Clinic of Dr. Moewardi General Hospital Surakarta from January 2018 to December 2022. 48 subjects included in this study 31 of them are females (65%). The subjects were dominated by those aged >50 years old (n:30; 63%). Herpes zoster mostly occurred at thoracal dermatome (n:22: 46%). Top three comorbidities were hypertension (n:10; 21%) followed by autoimmune diseases (n:9: 18%) and malignancy history (n; 6; 13%). Antiviral drugs (n:33; 69%) and antibiotic ointment (n:33; 69%) were the most therapy. More than 50% of subjects received anticonvulsant gabapentin (n:28; 58%) and one-fourth of subjects received analgesic (n:12; 25%). Herpes Zoster most affects middle adulthood population invo involving thoracal dermatome. Hypertension, autoimmune disease and history of malignancy are the common comorbidity. The main therapy of HZ is antivirus in combination with anticonvulsant and analgesic.

References

Ahn, J. H., Waller, J. L., Baer, S. L., Colombo, R. E., Kheda, M. F., Nahman Jr, N. S., & Turrentine, J. E. (2019). Mortality risk after herpes zoster infection in end-stage renal disease patients. Clinical Kidney Journal, 12(1), 101–105. https://doi.org/10.1093/ckj/sfy058

Bader, M. S. (2013). Herpes zoster: diagnostic, therapeutic, and preventive approaches. Postgraduate medicine, 125(5), 78-91. https://doi.org/10.3810/pgm.2013.09.2703

Carod-Artal, F. J. (2018). Infections of the spinal cord. CNS Infections: A Clinical Approach, 199-232. https://doi.org/10.1007/978-3-319-70296-4_10

Choi, H. G., Zehnder, J. L., Lee, Y. K., Lim, H., & Kim, M. (2019). Increased risk of lymphoid malignancy in patients with herpes zoster: a longitudinal follow-up study using a national cohort. BMC Cancer, 19, 1–9. https://doi.org/10.1186/s12885-019-6349-y

Chuanchaiyakul, N., Thongtang, N., & Rattanaumpawan, P. (2022). Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study. Journal of Diabetes and Its Complications, 36(5), 108168. https://doi.org/10.1016/j.jdiacomp.2022.108168

Devor, M. (2018). Rethinking the causes of pain in herpes zoster and postherpetic neuralgia: the ectopic pacemaker hypothesis. Pain reports, 3(6), e702. https://doi.org/10.1097/PR9.0000000000000702

Fitriani, F., Kariosentono, H., Prasetyorini, B. E., Oktriana, P., & Amelinda, N. (2021). Tata Laksana Herpes Zoster. Departemen Ilmu Kesehatan Kulit Dan Kelamin Fakultas Kedokteran Universitas Sebelas Maret Surakarta, Rumah Sakit Dr. Moewardi. Medical Review Journal, 34, 51.

Johnson, R. W., Wasner, G., Saddier, P., & Baron, R. (2008). Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs & aging, 25, 991-1006. https://doi.org/10.2165/0002512-200825120-00002

Marra, F., Parhar, K., Huang, B., & Vadlamudi, N. (2020). Risk factors for herpes zoster infection: a meta-analysis. Open Forum Infectious Diseases, 7(1), ofaa005. https://doi.org/10.1093/ofid/ofaa005

MN, O. (1981). Varicella and herpes zoster. Medical Microbiology and Infectious Diseases, 1652–1671.

Patil, A., Goldust, M., & Wollina, U. (2022). Herpes zoster: a review of clinical manifestations and management. Viruses, 14(2), 192.

San Martin, P., Aunhachoke, K., Batac, M. C. F., Lodrono-Lim, K., Kwanthitinan, C., Santoso, D., Fonseka, T., Nguyen, M., & Guzman-Holst, A. (2023). Systematic literature review of herpes zoster disease burden in Southeast Asia. Infectious Diseases and Therapy, 12(6), 1553–1578. https://doi.org/10.1007/s40121-023-00822-0

Song, P., Zhang, Y., Zha, M., Yang, Q., Ye, X., Yi, Q., & Rudan, I. (2021). The global prevalence of essential tremor, with emphasis on age and sex: a meta-analysis. Journal of global health, 11. https://doi.org/10.7189/jogh.11.04028

Tanaka, K., Kimura, E., Oryoji, K., Mizuki, S., Kobayashi, T., Nishikawa, A., Yoshinaga, E., & Miyake, Y. (2021). Hypertension and dyslipidemia are risk factors for herpes zoster in patients with rheumatoid arthritis: a retrospective analysis using a medical information database. Rheumatology International, 41, 1633–1639. https://doi.org/10.1007/s00296-021-04889-1

Vlak, M. H., Algra, A., Brandenburg, R., & Rinkel, G. J. (2011). Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. The Lancet Neurology, 10(7), 626-636. https://doi.org/10.1016/S1474-4422(11)70109-0